← Medication & Supplement Reference

VETERINARY TEAM REFERENCE · MEDICATION

Romifidine

Updated October 27, 2026 · Sources and review status below

For veterinarians and veterinary staff. Product-label information is distinct from extra-label clinical practice. This is not a complete prescribing formulary or an automated interaction screen. Verify the current label, exact formulation, patient and species-specific clinical reference before use. Independent veterinary/pharmacy review remains pending.

Prescribing overview

An equine injectable sedative and analgesic with U.S. adult-horse conditions of use; current safety details below are explicitly from Great Britain labeling.

Alpha-2 adrenergic agonistProduct-specific clinical reference

The current U.S. regulation describes adult-horse procedural sedation/analgesia and preanesthesia. This entry supplements that narrow regulatory scope with the September 2026 Great Britain SPC, clearly identified so that its warnings are not mistaken for current U.S. product labeling.

Key prescribing checks

  • Review the source-specific safety card and monitoring plan before use.

Uses by species

Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.

Horses

U.S. labeled/regulatory equine use; see exact scope

Sedation/analgesia for handling, examinations, minor procedures and preanesthesia in adult horses

U.S. eCFR indication; verify an available lawful product and its actual labeling before use.

Use / indication source ↗

Pharmacology & pharmacokinetics

Mechanism and clinical role

Great Britain manufacturer information describes central alpha-2 receptor-mediated sedation and analgesia.

Absorption, distribution, metabolism and elimination

Manufacturer information describes predominantly urinary elimination and inactive metabolites; these data do not establish a patient-specific redosing interval.

SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC

Contraindications & cautions

Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.

Sedivet

Great Britain Sedivet SPC safety summary; separate U.S. regulatory indication noted.

Contraindications · when not to use

  • Great Britain SPC: do not use in the last month of pregnancy.

Precautions & monitoring

  • Safety statements in this card are Great Britain product information, not a substituted U.S. insert.
  • U.S. regulation excludes horses intended for human consumption.

This is a selected source summary, not exhaustive prescribing guidance.

Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.

Adverse effects

The Great Britain SPC lists bradycardia, heart block, hypotension, ataxia, sweating and hypersensitivity; cardiovascular disease requires particular care.

These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.

Dosing & administration

Verify the source before prescribing. The regimens below summarize selected veterinary product labels, not every accepted veterinary use. They are not automatic substitutions between brands or formulations. Renal/hepatic disease, concurrent therapy, age, indication and clinical response can require a different plan.

A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.

No numerical regimen or automatic calculation. Confirm jurisdiction, actual product availability and current local prescribing information.

Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗

Drug & supplement interactions

This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.

Compare with other medications and check species →

Sedivet

Great Britain Sedivet SPC safety summary; separate U.S. regulatory indication noted.

  • Great Britain SPC advises against IV potentiated sulfonamides during sedation because potentially fatal arrhythmias have been reported with this class.
  • Other psychoactive drugs can potentiate sedation and reduce anesthetic requirements.
Interaction source ↗Interaction source ↗Interaction source ↗

Monitoring

Assess cardiovascular status, respiration, sedation depth and safe recovery; defensive kicking can persist despite apparent sedation.

Client counseling

Use a quiet recovery environment. Accidental human self-injection needs immediate medical assessment; do not drive.

This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.

Storage & handling

Follow the actual product label; Great Britain SPC specifies a first-opening use limit and prohibits mixing without compatibility data.

Brands, formulations & ingredient identity

Active ingredients

Romifidine hydrochloride

Other searchable names: Sedivet

Sedivet is a verified romifidine brand. U.S. approval history does not confirm current U.S. commercial availability or the equivalence of compounded products.

Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.

Sedivet

Formulation
Romifidine hydrochloride injection
Label / product scope
Horses

Safety scope: Great Britain SPC. U.S. availability not confirmed.

Product label / source ↗

References & review status

Clinical reference updated October 27, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.

Search another medication or supplement →

CONTINUE EXPLORING

Use these connected guides to prepare informed questions for your veterinary team.

Find Veterinary Care Near YouLocate general practices, urgent-care clinics, emergency hospitals and specialists.Read resource →When It Is an EmergencyRecognize signs that require immediate veterinary care.Read resource →Interactive Symptom NavigatorStart with what you notice and understand when to seek help.Read resource →Poisons and Household HazardsRecognize common exposures and avoid unsafe home treatment.Read resource →Printable Owner ToolkitBring observations, medication details and questions to your appointment.Read resource →
Privacy & cookie choices